Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Xiao‐Ou Shu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0711-8314; OpenAlex author ID A5012016075, A5085657415; NIH RePORTER profile ID 1894075. Sources: OpenAlex.

Their work

Papers
37 (first author 1, last author 4)
Trials
0
Grants
3
Labs led
2
Collaborators
83
Papers, trials and grants by year

2012: 1 paper · 2013: 3 papers · 2014: 2 papers · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 4 papers, 1 grant · 2019: none · 2020: 6 papers, 1 grant · 2021: 6 papers · 2022: 2 papers · 2023: 2 papers, 1 grant · 2024: 2 papers · 2025: 1 paper · 2026: 4 papers

Papers 37

  1. Dynamics of the association between circulating levels of miRNA and pancreatic cancer risk through the years prior to pancreatic cancer diagnosis. Last author DOI 10.1002/ijc.70452↗
  2. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  3. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  4. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  5. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  6. Circulating microRNAs in association with pancreatic cancer risk within 5 years. Last author DOI 10.1002/ijc.34956↗
  7. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  8. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Co-author DOI 10.1002/ijc.34287↗
  9. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  10. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  11. The oral microbiome in relation to pancreatic cancer risk in African Americans. Co-author DOI 10.1038/s41416-021-01578-5↗
  12. Red meat consumption, cooking mutagens, NAT1/2 genotypes and pancreatic cancer risk in two ethnically diverse prospective cohorts. Co-author DOI 10.1002/ijc.33598↗
  13. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  14. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  15. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  16. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0400↗
  17. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  18. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  19. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  20. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  21. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  22. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  23. Replication and Genetic Risk Score Analysis for Pancreatic Cancer in a Diverse Multiethnic Population. Co-author DOI 10.1158/1055-9965.epi-20-0963↗
  24. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. Last author DOI 10.1002/ijc.31574↗
  25. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  26. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  27. Physical Activity and Pancreatic Cancer Risk among Urban Chinese: Results from Two Prospective Cohort Studies. Last author DOI 10.1158/1055-9965.epi-17-0895↗
  28. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk. First author DOI 10.1002/ijc.31007↗
  29. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  30. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  31. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  32. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  33. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  34. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Co-author DOI 10.1007/s10552-012-0078-8↗
  35. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  36. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  37. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Co-author DOI 10.1093/carcin/bgs151↗

Grants 3

  1. Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer R01CA227133↗
  2. Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk R01CA204113↗
  3. A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer U01CA187508↗

Closest collaborators

The 25 strongest of 83 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Veronica Wendy Setiawan · 4 shared papers, 1 shared grant, 2020–2026 · strength 1.47
  2. Qiuyin Cai · 7 shared papers, 2017–2026 · strength 1.03
  3. Wei Zheng · 11 shared papers, 2013–2024 · strength 1.00
  4. Hui Cai · 5 shared papers, 2018–2026 · strength 0.82
  5. Rachael Z. Stolzenberg‐Solomon · 6 shared papers, 2013–2026 · strength 0.71
  6. Julie R Palmer · 1 shared paper, 1 shared grant, 2018–2022 · strength 0.48
  7. Fei Ye · 2 shared papers, 2024–2026 · strength 0.47
  8. Jordan D. Berlin · 2 shared papers, 2024–2026 · strength 0.47
  9. Yu‐Tang Gao · 4 shared papers, 2017–2024 · strength 0.41
  10. Lang Wu · 4 shared papers, 2018–2021 · strength 0.40
  11. Zhiheng Pei · 1 shared grant, 2020 · strength 0.38
  12. Yu Chen · 1 shared grant, 2020 · strength 0.38
  13. Jirong Long · 3 shared papers, 2020–2022 · strength 0.31
  14. Dominique S. Michaud · 3 shared papers, 2013–2022 · strength 0.26
  15. Brian Matthew Wolpin · 3 shared papers, 2013–2022 · strength 0.25
  16. Xiang Shu · 3 shared papers, 2018–2021 · strength 0.25
  17. Gloria M. Petersen · 4 shared papers, 2013–2022 · strength 0.24
  18. David Daniel Bogumil · 2 shared papers, 2020–2021 · strength 0.23
  19. William J. Blot · 2 shared papers, 2020–2021 · strength 0.23
  20. Stephen Jacob Pandol · 2 shared papers, 2020–2021 · strength 0.23
  21. Roger Laughlin Milne · 3 shared papers, 2018–2022 · strength 0.22
  22. Harvey A. Risch · 3 shared papers, 2018–2022 · strength 0.22
  23. Paige M. Bracci · 3 shared papers, 2018–2022 · strength 0.22
  24. Charles L Kooperberg · 3 shared papers, 2013–2022 · strength 0.19
  25. Cong Wang · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.